NT5E and melanoma: Several serum markers associated with melanoma survival or response to therapy, including lactate dehydrogenase and CD73, have been described, but few studies have successfully identified and validated serum or CSF markers of melanoma-associated IMD, which occurs in over 50% of melanoma patients [99,100,101].